New Delhi: As part of the vaccination trial for children in the age group of 2-6 years, the second dose of Covaxin is likely to be administered next week.
A report in India Today quoted All India Institute of Medical Sciences (AIIMS) Delhi officials as saying that the second dose of Covaxin has already been administered to those who are part of the trial in 6-12 age group.
Kids’ trials for Covaxin, the indigenous vaccine developed by Hyderabad-based Bharat Biotech, is being pushed keeping in mind the third wave of the COVID-19 pandemic which experts have said is inevitable in India.
Once all 175 participants in the 2-6 age group trial have received the second dose, an interim report is expected by the end of August. Based on the trial report, it will be decided if the vaccine is safe for children.
AIIMS director Dr Randeep Guleria said earlier that Covaxin is likely to be approved for children in September.
Covaxin apart, Zydus Cadila’s three-dose shot ZyCov-D is the other vaccine which experts believe could be approved for children in a few months’ time.
Bhubaneswar: A 20-year-old married woman, allegedly kidnapped from Odisha's Nabarangpur and then raped, and held…
New York: Slamming the prolonged delays in some parts of United States, Elon Musk on…
Cuttack: Madhupatana Police recently rescued a 17-year-old Bangladeshi girl, a suspected victim of trafficking and…
Mumbai: With the Bharatiya Janata Party (BJP), Shiv Sena and the NCP alliance emerging victorious in…
Balasore: The driver of a container truck was charred to death after the vehicle caught…
Nuapada: At least 80 people were arrested during a massive crackdown on illegal gambling activities…
Bhubaneswar: The Odisha government has transferred Special Secretary, Planning and Convergence, Chitra Arumugam and posted…
Sambhal: A violent clash erupted in Uttar Pradesh’s Sambhal on Sunday after a group opposed…